Vera J Suman

Vera J Suman

UNVERIFIED PROFILE

Are you Vera J Suman?   Register this Author

Register author
Vera J Suman

Vera J Suman

Publications by authors named "Vera J Suman"

Are you Vera J Suman?   Register this Author

100Publications

2958Reads

43Profile Views

The emerging role of CDK4/6i in HER2-positive breast cancer.

Ther Adv Med Oncol 2019 27;11:1758835919887665. Epub 2019 Nov 27.

Department of Oncology, Mayo Clinic, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1758835919887665DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6887797PMC
November 2019

Tamoxifen Metabolism and Breast Cancer Recurrence: A Question Unanswered by CYPTAM.

J Clin Oncol 2019 Aug 18;37(22):1982-1983. Epub 2019 Jun 18.

Matthew P. Goetz, MD and Vera J. Suman, PhD, Mayo Clinic, Rochester, MN; Yusuke Nakamura, MD, PhD and Kazuma Kiyotani, PhD, Cancer Precision Medicine Center, Tokyo, Japan; V. Craig Jordan, PhD, DSc, The University of Texas MD Anderson Cancer Center, Houston, TX; and James N. Ingle, MD, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
https://ascopubs.org/doi/10.1200/JCO.19.00504
Publisher Site
http://dx.doi.org/10.1200/JCO.19.00504DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6675592PMC
August 2019

Spontaneous murine tumors in the development of patient-derived xenografts: a potential pitfall.

Oncotarget 2019 Jun 11;10(39):3924-3930. Epub 2019 Jun 11.

Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.27001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6570466PMC
June 2019

Commentary on "Is posttransplant lenalidomide the standard-of-care after an autotransplant for plasma cell myeloma" by Giovanni Barosi and Robert Peter Gale.

Leukemia 2019 02 11;33(2):565-566. Epub 2019 Jan 11.

Department of Medicine, Transplant and Cellular Therapy Program, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41375-018-0359-7
Publisher Site
http://dx.doi.org/10.1038/s41375-018-0359-7DOI Listing
February 2019

Should Overall Survival Remain an Endpoint for Multiple Myeloma Trials?

Curr Hematol Malig Rep 2019 02;14(1):31-38

Department of Medicine, Blood and Marrow Transplant Center, Transplant and Cellular Therapy Program, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-019-0495-9DOI Listing
February 2019

Update on the role of lenalidomide in patients with multiple myeloma.

Ther Adv Hematol 2018 Jul 26;9(7):175-190. Epub 2018 May 26.

Department of Medicine, Blood and Marrow Transplant Center, Roswell Park Comprehensive Cancer Center, Buffalo, Elm and Carlton Streets, CSC 815, NY 14263, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2040620718775629DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6041862PMC
July 2018

Comparison of a Medical-Grade Monitor vs Commercial Off-the-Shelf Display for Mitotic Figure Enumeration and Small Object (Helicobacter pylori) Detection.

Am J Clin Pathol 2018 Jan;149(2):181-185

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ajcp/aqx154DOI Listing
January 2018

Cytoplasmic Cyclin E Mediates Resistance to Aromatase Inhibitors in Breast Cancer.

Clin Cancer Res 2017 Dec 25;23(23):7288-7300. Epub 2017 Sep 25.

Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/lookup/doi/10.1158/107
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-17-1544DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5768442PMC
December 2017

ERβ inhibits cyclin dependent kinases 1 and 7 in triple negative breast cancer.

Oncotarget 2017 Nov 11;8(57):96506-96521. Epub 2017 Oct 11.

Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://www.oncotarget.com/fulltext/21787
Publisher Site
http://dx.doi.org/10.18632/oncotarget.21787DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722501PMC
November 2017

First-in-Human Phase I Study of the Tamoxifen Metabolite Z-Endoxifen in Women With Endocrine-Refractory Metastatic Breast Cancer.

J Clin Oncol 2017 Oct 30;35(30):3391-3400. Epub 2017 Aug 30.

Matthew P. Goetz, Vera J. Suman, Joel M. Reid, Don W. Northfelt, Michael A. Mahr, Andrew T. Ralya, Mary Kuffel, Sarah A. Buhrow, Stephanie L. Safgren, Renee M. McGovern, John Black, Travis Dockter, Tufia Haddad, Charles Erlichman, Alex A. Adjei, Dan Visscher, Benjamin R. Kipp, Minetta C. Liu, John R. Hawse, Matthew M. Ames, and James N. Ingle, Mayo Clinic, Rochester, MN; Zachary R. Chalmers and Garrett Frampton, Foundation Medicine, Cambridge, MA; and John R. Hawse, James H. Doroshow, Jerry M. Collins, and Howard Streicher, National Cancer Institute, Bethesda, MD.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2017.73.3246
Publisher Site
http://dx.doi.org/10.1200/JCO.2017.73.3246DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5648176PMC
October 2017

Phase II trial of pazopanib in advanced/progressive malignant pheochromocytoma and paraganglioma.

Endocrine 2017 Aug 6;57(2):220-225. Epub 2017 Jul 6.

Division of Medical Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12020-017-1359-5DOI Listing
August 2017

Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance).

J Clin Oncol 2017 Apr 3;35(10):1061-1069. Epub 2017 Jan 3.

Matthew J. Ellis and Chad J. Creighton, Baylor College of Medicine; Gildy Babiera and Kelly Hunt, MD Anderson Cancer Center, Houston; Gary Unzeitig, Doctor's Hospital of Laredo, Laredo; Marilyn Leitch, University of Texas Southwestern Campus, Dallas, TX; Vera J. Suman, Mayo Clinic, Rochester MN; Jeremy Hoog, Rodrigo Goncalves, Souzan Sanati, Katherine DeSchryver, Erika Crouch, Amy Brink, Mark Watson, Jingqin Luo, Yu Tao, Cynthia X. Ma, and D. Craig Allred, Washington University School of Medicine, St Louis; Timothy Pluard, St Lukes Hospital, Kansas City, MO; Michael Barnes, Roche Diagnostics, Mountain View; Laura Esserman, University of California San Francisco, San Francisco, CA; Mitchell Dowsett, Royal Marsden Hospital, London, UK; G. Thomas Budd, Cleveland Clinic; Paula Silverman, Case Western Reserve University, Cleveland OH; Eric Winer, Dana-Farber Cancer Institute, Boston MA; Lisa Carey, University of North Carolina, Chapel Hill; David Ota, Duke University, Durham, NC; Pat Whitworth, Nashville Breast Center, Nashville, TN; J. Michael Guenther, St Elizabeth Medical Center, Edgewood, KY; Zoneddy Dayao, University of New Mexico, Albuquerque, NM; and John A. Olson Jr, University of Maryland School of Medicine and Greenebaum Cancer Center, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.69.4406DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455353PMC
April 2017

Safety and Feasibility of Minimally Invasive Inguinal Lymph Node Dissection in Patients With Melanoma (SAFE-MILND): Report of a Prospective Multi-institutional Trial.

Ann Surg 2017 01;265(1):192-196

*Department of Surgery, Mayo Clinic, Rochester, MN †Department of Surgery, Ohio State University Medical Center, Columbus, OH ‡Department of Surgery, H. Lee Moffitt Cancer Center, Tampa, FL §Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY ¶Department of Surgical Oncology, John Wayne Cancer Institute, Santa Monica, CA ||Department of Surgery, Duke University School of Medicine, Durham, NC **Division of General Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI ††Department of Surgery, Mayo Clinic, Phoenix, AZ ‡‡Department of Surgery, Fox Chase Cancer Center, Philadelphia, PA §§Department of Surgery, MetroHealth Medical Center, Cleveland, OH ¶¶Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL ||||Department of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN ***Department of Surgery, University of Texas Medical Branch, Galveston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/SLA.0000000000001670DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4999343PMC
January 2017

Status of the Regional Nodal Basin Remains Highly Prognostic in Melanoma Patients with In-Transit Disease.

J Am Coll Surg 2016 07 26;223(1):77-85.e1. Epub 2016 Mar 26.

Department of Medical Oncology, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jamcollsurg.2016.03.025DOI Listing
July 2016

Immunologic Autograft Engineering and Survival in Non-Hodgkin Lymphoma.

Biol Blood Marrow Transplant 2016 06 27;22(6):1017-1023. Epub 2016 Jan 27.

Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.01.024DOI Listing
June 2016

Window-of-Opportunity Trials in the Preoperative Setting: Insights Into Drug Development for Estrogen Receptor-Positive Breast Cancer.

J Clin Oncol 2016 06 21;34(17):1970-2. Epub 2016 Mar 21.

Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.66.2312DOI Listing
June 2016

Aberrant Glycosylation of Anchor-Optimized MUC1 Peptides Can Enhance Antigen Binding Affinity and Reverse Tolerance to Cytotoxic T Lymphocytes.

Biomolecules 2016 06 29;6(3). Epub 2016 Jun 29.

Department of Biochemistry and Molecular Biology, College of Medicine, Mayo Clinic in Arizona, 13400 E. Shea Boulevard, Scottsdale, AZ 85259, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039417PMC
http://dx.doi.org/10.3390/biom6030031DOI Listing
June 2016

Evaluation of the Aromatase Inhibition Potential of Freeze-Dried Grape Powder.

J Diet Suppl 2015 Dec 28;12(4):373-382. Epub 2014 Aug 28.

c 3 Health Sciences Research Department , Mayo Clinic College of Medicine Rochester, Minnesota, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/19390211.2014.952863DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4873455PMC
December 2015

Tumor Cell Adhesion As a Risk Factor for Sentinel Lymph Node Metastasis in Primary Cutaneous Melanoma.

J Clin Oncol 2015 Aug 6;33(23):2509-15. Epub 2015 Jul 6.

Alexander Meves, Ekaterina Nikolova, Joel B. Heim, Edwin J. Squirewell, Clark C. Otley, Louis A. Schenck, Amy L. Weaver, and Vera J. Suman, Mayo Clinic, Rochester, MN; Mark A. Cappel, Mayo Clinic, Jacksonville, FL; Mark R. Pittelkow, Mayo Clinic, Scottsdale, AZ; and Nille Behrendt, Ditte M. Saunte, and Jorgen Lock-Andersen, Hospital Roskilde, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.60.7002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979232PMC
August 2015

Reporting of results in DART01/05 GICOR.

Lancet Oncol 2015 Jun 27;16(6):e258. Epub 2015 May 27.

Cedars-Sinai Medical Center, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(15)70243-3DOI Listing
June 2015

Evaluation of CYP2D6 enzyme activity using a 13C-dextromethorphan breath test in women receiving adjuvant tamoxifen.

Pharmacogenet Genomics 2015 Apr;25(4):157-63

Departments of aOncology bMolecular Pharmacology and Experimental Therapeutics cBiostatistics dLaboratory Medicine, Mayo Clinic, Rochester, Minnesota eDepartment of Hematology and Oncology, Mayo Clinic, Scottsdale, Arizona fCambridge Isotope Laboratories Inc. gPhysical Sciences Inc., Andover, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0000000000000121DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4356640PMC
April 2015

Factors affecting sentinel lymph node identification rate after neoadjuvant chemotherapy for breast cancer patients enrolled in ACOSOG Z1071 (Alliance).

Ann Surg 2015 Mar;261(3):547-52

*Mayo Clinic, Rochester, MN †Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN ‡MD Anderson Cancer Center, Houston, TX §University of Pittsburgh, Pittsburgh, PA ¶University of Wisconsin, Madison, WI ‖Columbia University Medical Center, New York, NY **University of Texas Southwestern Medical Center, Dallas, TX ††Carolinas Medical Center, Charlotte, NC; and ‡‡Indiana University Medical Center, Indianapolis, IN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/SLA.0000000000000551DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324533PMC
March 2015

Loss of heterozygosity at the CYP2D6 locus in breast cancer: implications for germline pharmacogenetic studies.

J Natl Cancer Inst 2014 Dec 8;107(2). Epub 2014 Dec 8.

Department of Oncology (MPG, MMA, JNI), Department of Health Sciences Research (VJS, KRK), and Department of Molecular Pharmacology and Experimental Therapeutics (MPG, SLS, MK, MMA), Mayo Clinic, Rochester, MN; Department of Genetics, University of North Carolina, Chapel Hill, NC (GOS, CMP); Center for Personalized Therapeutics, University of Chicago, Chicago, IL (YN, NJC, MJR); Foundation Medicine Inc., Cambridge, MA (JXS, PJS, VAM, JSR, RY); Novartis Pharmaceuticals Corporation, East Hanover, NJ (DC); Department of Pathology and Laboratory Medicine, Albany Medical College, Albany, NY (JSR); Division of Hematology/Oncology, Vanderbilt University, Nashville, TN (HG); Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX (AMGA, OB); Department Breast Cancer Susceptibility and Pharmacogenomics, Dr Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, University Tuebingen, German Cancer Consortium (DKTK) and German Cancer Research (DKTK), Heidelberg, Germany (HB).Current affiliation of H. Gomez: Departamento de Medicina Oncologica, Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dju401DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4565524PMC
December 2014

Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2-positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG N9831.

J Clin Oncol 2014 Nov 20;32(33):3744-52. Epub 2014 Oct 20.

Edith A. Perez, Gerardo Colon-Otero, the Mayo Clinic, Jacksonville; Eleftherios Mamounas, University of Florida Health Cancer Center-Orlando Health, Orlando, FL; Edward H. Romond, University of Kentucky, Lexington, KY; Vera J. Suman, Mayo Clinic, Rochester, MN; Jong-Hyeon Jeong, Priya Rastogi, University of Pittsburgh; Nancy E. Davidson, University of Pittsburgh Cancer Institute; Norman Wolmark, Allegheny General Hospital, Pittsburgh, PA; George Sledge, Stanford University School of Medicine, Stanford; Silvana Martino, The Angeles Clinic and Research Institute, Santa Monica, CA; Charles E. Geyer Jr, Virginia Commonwealth University Massey Cancer Center, Richmond, VA; Julie Gralow, University of Washington/Seattle Cancer Care Alliance, Seattle, WA; Sandra M. Swain, MedStar Washington Hospital Center, Washington, DC; Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Jo Anne Zujewski, National Institutes of Health, Rockville, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.55.5730DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226805PMC
November 2014

A multicenter phase 2 trial of pazopanib in metastatic and progressive medullary thyroid carcinoma: MC057H.

J Clin Endocrinol Metab 2014 May 25;99(5):1687-93. Epub 2014 Feb 25.

Division of Medical Oncology (K.C.B., J.R.M., J.R., K.S., J.K.B., K.P.W., C.R.I., C.E.), Division of Biomedical Statistics and Informatics (V.J.S.), Division of Endocrinology (J.C.M., B.M., I.H., V.F.), Mayo Clinic, Rochester, Minnesota 55905; Division of Endocrinology (R.C.S.), Division of Medical Oncology (W.J.M., M.E.M., C.B.), Mayo Clinic Florida, Jacksonville, Florida 32224; Division of Medical Oncology (N.K.), Mayo Clinic Arizona, Scottsdale, Arizona 85259; Carbone Cancer Center (A.M.T.), University of Wisconsin, Madison Wisconsin 53705; Minnesota Oncology Hematology (P.J.F.), PA, Minneapolis, Minnesota 55407; National University Hospital (C.G.), Singapore 119228; and Cancer Therapy Evaluation Program (P.H.), National Cancer Institute, Bethesda, Maryland 20892.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2013-3713DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4010705PMC
May 2014

Quantifying insulin receptor isoform expression in FFPE breast tumors.

Growth Horm IGF Res 2012 Jun-Aug;22(3-4):108-15. Epub 2012 Apr 30.

Department of Oncology, Mayo Clinic, Rochester, MN 55905, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ghir.2012.04.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3392524PMC
June 2013

A phase I trial of the IGF-1R antibody Cixutumumab in combination with temsirolimus in patients with metastatic breast cancer.

Breast Cancer Res Treat 2013 May 19;139(1):145-53. Epub 2013 Apr 19.

Section of Breast Oncology, Division of Oncology, Department of Internal Medicine, Washington University School of Medicine, 660 South Euclid Avenue, P.O. Box 8056, St. Louis, MO 63110, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-013-2528-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4517667PMC
May 2013

Evaluation of serum estrogen-DNA adducts as potential biomarkers for breast cancer risk.

J Steroid Biochem Mol Biol 2012 Oct 24;132(1-2):73-9. Epub 2012 Feb 24.

Division of General Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jsbmb.2012.02.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3378787PMC
October 2012

Identifying patients with follicular lymphoma who are likely to benefit from an idiotype vaccine.

J Clin Oncol 2011 Jul 31;29(20):2748-9. Epub 2011 May 31.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2011.35.8812DOI Listing
July 2011

Menstrual cycle and surgical treatment of breast cancer: findings from the NCCTG N9431 study.

J Clin Oncol 2009 Aug 1;27(22):3620-6. Epub 2009 Jun 1.

Division of General Surgery, Mayo Clinic, North Central Cancer Treatment Group, Dept of Surgery, 200 1st St SW, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2008.21.3603DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2799061PMC
August 2009

Clinical trials of novel and targeted therapies: endpoints, trial design, and analysis.

Cancer Invest 2008 Jun;26(5):439-44

Division of Biostatistics, Mayo Clinic, Rochester, Minnesota, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/07357900801971057DOI Listing
June 2008

Molecular analysis of metaplastic breast carcinoma: high EGFR copy number via aneusomy.

Mol Cancer Ther 2008 Apr;7(4):944-51

Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-07-0570DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2745608PMC
April 2008

Breast biopsy utilization: a population-based study.

Arch Intern Med 2005 Jul;165(14):1593-8

Division of General Internal Medicine, Department of Internal Medicine, Mayo Clinic, Rochester, Minn 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/archinte.165.14.1593DOI Listing
July 2005

Evaluation of a panel of tumor markers for molecular detection of circulating cancer cells in women with suspected breast cancer.

Clin Cancer Res 2005 May;11(10):3722-32

Divisions of Experimental Pathology and Biostatistics, and Department of Oncology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-04-1483DOI Listing
May 2005

Aromatase inhibitors for therapy of advanced breast cancer.

J Steroid Biochem Mol Biol 2005 May;95(1-5):113-9

Division of Medical Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S096007600500193
Publisher Site
http://dx.doi.org/10.1016/j.jsbmb.2005.04.014DOI Listing
May 2005

Serum soluble epidermal growth factor receptor concentrations decrease in postmenopausal metastatic breast cancer patients treated with letrozole.

Cancer Res 2005 Apr;65(8):3059-62

Tumor Biology Program, Cancer Center Statistics Unit, Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-05-0067DOI Listing
April 2005